Additional effect of topical coal tar in adults with atopic dermatitis.

Phase 1

• Conditions: Atopic Dermatitis (AD); MedDRA version: 19.1Level: LLTClassification code 10003639Term: Atopic dermatitisSystem Organ Class: 100000004858; Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]

• Registration Number: EUCTR2016-004687-19-NL
• Lead Sponsor: Radboud University Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-01-25
• Last Update Posted: 8 October 2021

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 56

Inclusion Criteria

-Male or female patients aged >16 years of age
-Diagnosis of AD based on the criteria of Hanifin and Rajka
-Moderate to severe AD based on EASI score >7.1

Are the trial subjects under 18? yes
Number of subjects for this age range: 5
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 46
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 5

Exclusion Criteria

-Hypersensitivity and/or intolerance to topical corticosteroids or topical coal tar
-Indication for systemic therapy or a medical need to use a higher level of topical corticosteroids than potent topical corticosteroids

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified